Patient PreferenceNCT05999279
Patient Preferences With Pharmaceutical Care: In-person Versus Digital Health
An observational study of Patient Preference, run by Lebanese University at 2 sites in Lebanon.
Trial summary
Digital pharmaceutical care, also known as e-pharmaceutical care or telepharmacy, refers to using digital technologies to provide remote pharmaceutical care services. It involves the application of digital tools and platforms to deliver medication-related services, patient counseling, medication management, and other… Read more about this study
- Who is it for?
- Ages 18 to 75 years
- Conditions the study is for
- Patient Preference
- What is being tested?
- Survey
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 386 participants
- Where
- 2 sitesLebanon
- Study dates
- 1 Jul 2023to 1 Oct 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- Adult, Older adult
Study population: Adult individuals who visited two community pharmacies during the data collection period. No criteria were based on sex, race, nationality, or ethnicity.
Who may be able to join
- Patients who took at least one medication in the past month
- Patient visiting two community pharmacies
Who cannot join
- Those refusing to participate
- Those with severe hearing or mental problems
Trial locations and contacts
2 sites in 1 country.
Lebanon2 sites
Pharmacy Bouchi
Beirut, Mount Lebanon, 0000
Pharmacy du Liban
Beirut, 0000
About this study
Official title: A Cross-sectional Study Addressing Lebanese Patient Preferences With Pharmaceutical Care: Traditional Versus Digital Health?
Digital pharmaceutical care, also known as e-pharmaceutical care or telepharmacy, refers to using digital technologies to provide remote pharmaceutical care services. It involves the application of digital tools and platforms to deliver medication-related services, patient counseling, medication management, and other pharmaceutical care activities. It allows patients to access pharmaceutical services conveniently from their homes or any location with an internet connection. This is particularly beneficial for individuals with limited mobility, those living in rural or underserved areas, or patients with difficulty visiting a physical pharmacy. However, it is essential to note that while digital pharmaceutical care provides many benefits, it may only suit some patients or situations. Some individuals may still prefer face-to-face interactions or may require hands-on assistance, especially for complex medication management. Healthcare providers should assess the appropriateness of digital solutions on a case-by-case basis and ensure patient privacy and data security when implementing digital pharmaceutical care services.
- Conditions
- Patient Preference
- Being tested
- Survey
- Keywords
- pharmaceutical care, preference, digital care
- Medical subject headings
- Patient Preference
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SurveyBehavioural
Developed questionnaire to assess the literacy of patients + another survey to assess their preferences regarding traditional versus digital pharmaceutical care
| Study group | Role | What they receive |
|---|---|---|
| Patient | Convenient sampling of patients who took at least one medication in the past month Receives: Behavioral: Survey |
What is being measured
The primary outcome is the main question the study is designed to answer.
Patient preference
A self-reported questionnaire was developed and piloted on the first 30 patients visiting the pharmacies. Minor modifications were performed taking into consideration two expert reviews. It is available in Arabic (native language) and English based on participants' preferences. It includes 3 parts: the first part comprises the baseline characteristics of the patients and their medical history/habits; the second part reports patients' preferences, benefits and disadvantages of each of the outcomes (in-person versus digital health); and the third part assess e-literacy among them using the e-HEALS 8-item scale previously validated on the Arab population.
Measured: through study completion, an average of 2 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Aug 2023
- Study start1 Jul 2023
- Primary completion1 Oct 2023
- Study completion1 Oct 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Patient PreferenceStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Enrolment
- 386 participants (actual)
Sponsor and investigators
- Lead sponsor
- Lebanese University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Georges Hatem, Lebanese University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05999279
- Sponsor's protocol ID
- 12/23/D
- Status last verified
- Oct 2023
- First submitted
- 3 Aug 2023
- Last updated
- 3 Oct 2023
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Oct 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Cross-sectional Study Addressing Lebanese Patient Preferences With Pharmaceutical Care: Traditional Versus Digital Health?
- ClinicalTrials.gov ID
- NCT05999279
- Acronym / sponsor ID
- 12/23/D
- Conditions
- Patient Preference
- Keywords
- pharmaceutical care, preference, digital care
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 386 participants (actual)
- Lead sponsor
- Lebanese UniversityUniversity, hospital or other
- Study start
- 1 Jul 2023 (actual)
- Primary completion
- 1 Oct 2023 (actual)
- Study completion
- 1 Oct 2023 (actual)
- First posted
- 21 Aug 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Digital pharmaceutical care, also known as e-pharmaceutical care or telepharmacy, refers to using digital technologies to provide remote pharmaceutical care services. It involves the application of digital tools and platforms to deliver medication-related services, patient counseling, medication management, and other pharmaceutical care activities. It allows patients to access pharmaceutical services conveniently from their homes or any location with an internet connection. This is particularly beneficial for individuals with limited mobility, those living in rural or underserved areas, or patients with difficulty visiting a physical pharmacy. However, it is essential to note that while digital pharmaceutical care provides many benefits, it may only suit some patients or situations. Some individuals may still prefer face-to-face interactions or may require hands-on assistance, especially for complex medication management. Healthcare providers should assess the appropriateness of digital solutions on a case-by-case basis and ensure patient privacy and data security when implementing digital pharmaceutical care services.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patient | – | Behavioral: SurveyConvenient sampling of patients who took at least one medication in the past month |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Adult individuals who visited two community pharmacies during the data collection period. No criteria were based on sex, race, nationality, or ethnicity.
Key inclusion criteria (2 listed)
- Patients who took at least one medication in the past month
- Patient visiting two community pharmacies
Key exclusion criteria (2 listed)
- Those refusing to participate
- Those with severe hearing or mental problems
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SurveyDeveloped questionnaire to assess the literacy of patients + another survey to assess their preferences regarding traditional versus digital pharmaceutical care | Behavioural | Patient |
Primary outcome
Patient preference
Time frame: through study completion, an average of 2 months
A self-reported questionnaire was developed and piloted on the first 30 patients visiting the pharmacies. Minor modifications were performed taking into consideration two expert reviews. It is available in Arabic (native language) and English based on participants' preferences. It includes 3 parts: the first part comprises the baseline characteristics of the patients and their medical history/habits; the second part reports patients' preferences, benefits and disadvantages of each of the outcomes (in-person versus digital health); and the third part assess e-literacy among them using the e-HEALS 8-item scale previously validated on the Arab population.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Oct 2023.
- Individual participant dataSharing planned: No
Related trials for Patient Preference
Enrolling by invitationObservational study
Liver Transplantation Versus Conventional Medical Therapy for Low-Grade GEP-NET With Liver Metastases
Neuroendocrine Tumors
RecruitingObservational study
Patient Needs and Preferences for NSCL Cancer Treatment Monitoring
Lung Cancer (NSCLC)
Recruiting
Evaluating the Feasibility of Prehabilitation Delivery Models for Patients Preparing for Gynecologic Cancer Surgery
Prehabilitation, Preoperative Aerobic Training
Not yet recruiting
Radical CystEctomy or RaDio-chEMotherapy as Preferred Treatment for invasivE blaDder Cancer
Muscle Invasive Bladder Cancer
RecruitingObservational study
PERCE-MUCO: Perceptions and Expectations of People With Cystic Fibrosis Regarding a Change in Treatment
Cystic Fibrosis (CF)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Patient Preference, run by Lebanese University at 2 sites in Lebanon.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Lebanon. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Patient preference (time frame: through study completion, an average of 2 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Oct 2023.